ZNF556 and prostate carcinoma: SOX11 [36], CRISP3 [37], KIF18B [38], and MELK [39] expression levels have also been found to be positively correlated with poor prostate cancer patient prognostic outcomes, while ZNF556 has been associated with poor colon cancer patient prognosis [40].